An investor in NASDAQ:TSLA shares filed a lawsuit against Tesla Inc over alleged violations of Federal Securities Laws by Tesla Inc in connection with certain allegedly false and misleading statements in connection with its Model 3.
Investors who purchased shares of Tesla Inc (NASDAQ:TSLA) have certain options and for certain investors are short and strict deadlines running. Deadline: December 11, 2017. NASDAQ:TSLA investors should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
According to the complaint the plaintiff alleges on behalf of purchasers of Tesla Inc (NASDAQ:TSLA) common shares between May 4, 2016 and October 6, 2017, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 4, 2016 and October 6, 2017, the , defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that contrary to defendants’ representations that Tesla was prepared for the launch of its Model 3 sedan, in reality, Tesla had severely inadequate inventory and was woefully unprepared to launch Model 3 sedan as anticipated, and that as a result, Tesla’s public statements were materially false and misleading at all relevant times.
On October 2, 2017, Tesla Inc announced the Company’s vehicle production and deliveries for the third quarter of 2017. Tesla Inc cited “production bottlenecks” as the reason for its failure to meet its production goals for its Model 3 sedan.
On October 6, 2017, post-market, an article was published reporting, in part, that “[u]nknown to analysts, investors and the hundreds of thousands of customers who signed up to buy it, as recently as early September major portions of the Model 3 were still being banged out by hand, away from the automated production line, according to people familiar with the matter.”
Those who purchased shares of Tesla Inc (NASDAQ:TSLA) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego